Background illustration for clinical trials search

Chronic Kidney Disease Clinical Trials

Browse 337 Chronic Kidney Disease clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease

for
CKD - Chronic Kidney Disease
Location: Portland OR
Sponsor: Kaiser Permanente

Sex: All

Age: 18 - 70+

Code: NCT07857200

Recruiting

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

for
Renal Insufficiency, Chronic
Location: Savannah GA, Charlotte NC, Waterloo, Riverview FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07624305

Phase 3, Recruiting

Lifestyle Intervention In CKD

for
Chronic Kidney Disease, Hypertension
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07633145

Recruiting

Renal Impairment Study for Oral EC5026

for
Chronic Kidney Disease
Location: Sacramento CA
Sponsor: EicOsis Human Health Inc.

Sex: All

Age: 55+

Code: NCT07694544

Phase 1, Recruiting

A Study of Luspatercept in People With Anemia

for
Anemia, Chronic Kidney Disease
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07725497

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

for
Chronic Kidney Disease, Stage 4,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18 - 65

Code: NCT06741072

Phase 1, Recruiting

Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial

for
Perioperative Management, End Stage Kidney Disease (ESRD),
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT07339202

Recruiting

Breakthrough - T1DM and Chronic Kidney Disease

for
Diabete Type 1, Chronic Kidney Disease
Location: Miami FL, Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18 - 70

Code: NCT07592000

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

for
CKD, Metabolic Acidosis
Location: Fresh Meadows NY, New York NY, Newark DE, Margate FL,
Sponsor: Renibus Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07355062

Phase 3, Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

for
Chronic Kidney Diseases
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06927024

Recruiting

CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD

for
Chronic Kidney Disease, Diabetes
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT07210710

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

for
Chronic Kidney Disease
Location: Miami FL
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07235059

Phase 1, Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Houston NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906627

Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906640

Recruiting

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase 2, Recruiting

Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)

for
Diabetic Kidney Disease (DKD), Type 2 Diabetes Mellitus (T2DM),
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT07434791

Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

for
Obesity and Obesity-related Medical Conditions, Diabetes,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70+

Code: NCT07083557

Recruiting

Care Transitions App for Patients With Multiple Chronic Conditions

for
Heart Failure, Congestive Heart Failure, Diabetes,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 55+

Code: NCT06051058

Recruiting

The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

for
Chronic Kidney Disease, Kidney Transplant,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07222683

Recruiting

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

for
Chronic Kidney Disease, Pediatric Urology
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 1 - 25

Code: NCT06860711

Recruiting

What is chronic kidney disease?

Chronic kidney disease, or CKD, means the kidneys have been damaged and filter blood less well for three months or more. It is measured with two tests: eGFR, an estimate of filtering capacity calculated from blood creatinine, and a urine test for albumin, a protein that leaks when the kidneys are injured. Diabetes and high blood pressure cause about two thirds of kidney failure in the US; inflammatory kidney diseases such as glomerulonephritis and lupus nephritis, inherited conditions, and long term use of certain medicines cause most of the rest. Early CKD has no symptoms; later it causes swelling, tiredness, changes in urination, and nausea.

Treatment aims to slow the decline: controlling blood pressure and blood sugar, and medicines that protect the kidneys directly, including SGLT2 inhibitors, finerenone for kidney disease with type 2 diabetes, and semaglutide, approved in 2025 for people with diabetes and CKD. When the kidneys fail, options are dialysis or a transplant.

Article preview image

Our guide explains the stages of CKD and treatment options.

Chronic Kidney Disease Stages, and How Treatment Changes at Each One

Types of chronic kidney disease clinical trials

Who can participate in chronic kidney disease clinical trials?

The stages of CKD, and why they matter for trials

Do chronic kidney disease trial participants get paid?

How to enroll in a chronic kidney disease clinical trial